Public Acceptance Of Measures To Control Infectious Diseases Under Different Scenarios Of Severity And Transmissibility
This study considers how the acceptability of non-pharmaceutical interventions (NPI) might depend on scenarios about the severity and transmissibility of the disease. (Source: Value in Health)
Source: Value in Health - February 22, 2024 Category: International Medicine & Public Health Authors: David Epstein, Daniel P érez-Troncoso, Manuel Ruiz-Adame, José Alberto García-Castañeda Source Type: research
Is the Comparator in Your Diagnostic Cost-Effectiveness Model “Standard of Care”? Recommendations from Literature Reviews and Expert Interviews on How to Identify and Operationalise It
This research aimed to develop best-practice recommendations for identifying the “standard of care” (SoC) and integrate it when it is the comparator in diagnostic economic models (SoC comparator). (Source: Value in Health)
Source: Value in Health - February 22, 2024 Category: International Medicine & Public Health Authors: Sara Graziadio, Emily Gregg, A. Joy Allen, Paul Neveux, Brigitta Monz, Clare Davenport, Stuart Mealing, Hayden Holmes, Lavinia Ferrante di Ruffano Tags: Methodology Source Type: research
Economic evaluations of establishing opioid overdose prevention centers in 12 North American cities: a systematic review
Overdose prevention centers (OPCs) provide a safe place where people can consume pre-obtained drugs under supervision so that a life-saving medical response can be provided quickly in the event of an overdose. OPCs are programs that are established in Canada and have recently become legally sanctioned in only a few United States jurisdictions. (Source: Value in Health)
Source: Value in Health - February 22, 2024 Category: International Medicine & Public Health Authors: Czarina N. Behrends, Jared A. Leff, Weston Lowry, Jazmine M. Li, Erica N. Onuoha, Erminia Fardone, Ahmed M. Bayoumi, Kathryn E. McCollister, Sean M. Murphy, Bruce R. Schackman Tags: Systematic Literature Review Source Type: research
Development and valuation of a preference-weighted measure in Age-Related Macular Degeneration from the Vision Impairment in Low Luminance (VILL) questionnaire – A MACUSTAR report
This study generates VILL-UI (Vision Impairment in Low Luminance - Utility Index), a preference-weighted measure (PWM) derived from the VILL-33 measure for use in patients with age-related macular degeneration (AMD), and valued to generate UK and German preference weights. (Source: Value in Health)
Source: Value in Health - February 16, 2024 Category: International Medicine & Public Health Authors: Donna Rowen, Jill Carlton, Jan H. Terheyden, Robert P. Finger, Nyantara Wickramasekera, John Brazier, MACUSTAR ConsortiumH. Agostini Tags: Preference-Based Assessments Source Type: research
Acceptability of using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps
Evidence about the comparative effects of new treatments is typically collected in randomized controlled trials (RCTs). In some instances, RCTs are not possible, or their value is limited by an inability to capture treatment effects over the longer-term or in all relevant population subgroups. In these cases, non-randomized studies (NRS) using real-world data (RWD) are increasingly used to complement trial evidence on treatment effects for health technology assessment (HTA). However, there have been concerns over a lack of acceptability of this evidence by HTA agencies. (Source: Value in Health)
Source: Value in Health - February 16, 2024 Category: International Medicine & Public Health Authors: Manuel Gomes, Alex J. Turner, Cormac Sammon, Dalia Dawoud, Sreeram Ramagopalan, Alex Simpson, Uwe Siebert Tags: Policy Perspectives Source Type: research
Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A national representative study
To estimate a Saudi-specific value set for the five-level EQ-5D (EQ-5D-5L) questionnaire using the EuroQol Valuation Technology (EQ-VT) programme and the EuroQol Group ’s standard protocol. (Source: Value in Health)
Source: Value in Health - February 9, 2024 Category: International Medicine & Public Health Authors: Ahmed Al-jedai, Hajer almudaiheem, Tareq Al-Salamah, Muath Aldosari, Abdulaali R. Almutairi, Yasser Almogbel, Yazed AlRuthia, Abdullah U. Althemery, Mohammed Alluhidan, Bram Roudijk, Fredrick Dermawan Purba, Nancy Awad, Rita O ’jeil Source Type: research
Evaluating Recall Periods for Patient-Reported Outcome Measures: A Systematic Review of Quantitative Methods
The current guidance for selection of recall periods recommends considering the design of the study, nature of the condition, patient ’s burden and ability to recall, and intent of the outcome measure. Empirical study of the accuracy of recall periods is recommended; however, there is not consensus on how to quantitatively evaluate the consistency of results from patient-reported outcome measures (PROMs) with different recall pe riods. We conducted a systematic review to describe quantitative methods for evaluating results obtained from PROMs with differing recall periods to lay the groundwork for establishing consensus....
Source: Value in Health - February 8, 2024 Category: International Medicine & Public Health Authors: Cara Arizmendi, Suwei Wang, Samantha Kaplan, Kevin Weinfurt Tags: Systematic Literature Review Source Type: research
Evaluating Recall Periods for Patient-Reported Outcome Measures: A Systematic Review of Quantitative Methods
The current guidance for selection of recall periods recommends considering the design of the study, nature of the condition, patient ’s burden and ability to recall, and intent of the outcome measure. Empirical study of the accuracy of recall periods is recommended; however, there is not consensus on how to quantitatively evaluate the consistency of results from patient-reported outcome measures (PROMs) with different recall pe riods. We conducted a systematic review to describe quantitative methods for evaluating results obtained from PROMs with differing recall periods to lay the groundwork for establishing consensus....
Source: Value in Health - February 8, 2024 Category: International Medicine & Public Health Authors: Cara Arizmendi, Suwei Wang, Samantha Kaplan, Kevin Weinfurt Tags: Systematic Literature Review Source Type: research
Social Decision-Making Analysis: a general approach to inform decisions on resources in the public sector
Public expenditure aims to achieve social objectives by improving a range of socially valuable attributes of benefit (arguments in a social welfare function). Public expenditure is typically allocated to public sector budgets, where budget holders are tasked with meeting a subset of social objectives. (Source: Value in Health)
Source: Value in Health - February 3, 2024 Category: International Medicine & Public Health Authors: Francesco Longo, Karl Claxton, Susan Griffin, Anne Mason, Simon Walker, Helen Weatherly Source Type: research
Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study
To evaluate the psychometric properties of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C), which was developed to support primary and secondary endpoints in irritable bowel syndrome (IBS) with predominant constipation (IBS-C) clinical trials. (Source: Value in Health)
Source: Value in Health - February 2, 2024 Category: International Medicine & Public Health Authors: Lori McLeod, Claire Ervin, Sheri E. Fehnel, Sonya Eremenco, Robyn T. Carson, Jennifer Hanlon, Stephen Joel Coons, Patient-Reported Outcome Consortium ’s Irritable Bowel Syndrome Working Group Tags: Patient-Reported Outcomes Source Type: research
Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms –Constipation in a Prospective Observational Study
To evaluate the psychometric properties of the Diary for Irritable Bowel Syndrome Symptoms –Constipation (DIBSS-C), which was developed to support primary and secondary endpoints in irritable bowel syndrome with predominant constipation (IBS-C) clinical trials. (Source: Value in Health)
Source: Value in Health - February 2, 2024 Category: International Medicine & Public Health Authors: Lori McLeod, Claire Ervin, Sheri E. Fehnel, Sonya Eremenco, Robyn T. Carson, Jennifer Hanlon, Stephen Joel Coons, Patient-Reported Outcome Consortium ’s Irritable Bowel Syndrome Working Group Source Type: research
Meaningful symptomatic change in patients with myelofibrosis from the SIMPLIFY studies
This study determined the meaningful change threshold (MCT) for two momelotinib phase III trials, SIMPLIFY-1 and SIMPLIFY-2. (Source: Value in Health)
Source: Value in Health - February 2, 2024 Category: International Medicine & Public Health Authors: Stacie Hudgens, Srdan Verstovsek, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal McLornan, Mary Frances McMulllin, Jean-Jacques Kiladjian, Lynda Foltz, Uwe Platzbecker, Maria Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, An Source Type: research
Economic Evaluation of an Enhanced Post-Discharge Home-Based Care Program for Stroke Survivors
To examine the cost-effectiveness of an enhanced postdischarge home-based care program for stroke survivors compared with usual care. (Source: Value in Health)
Source: Value in Health - February 1, 2024 Category: International Medicine & Public Health Authors: Arkers Kwan Ching Wong, Shao Ling Wang, Ching So, Jinxiao Lian, Ying Yan, Haiyan Li, Lijie Wu, Haixia Pei, Wei Wang, Frances Kam Yuet Wong Tags: Economic Evaluation Source Type: research
Economic evaluation of an enhanced post-discharge home-based care program (EHP) for stroke survivors
To examine the cost-effectiveness of an enhanced post-discharge home-based care program for stroke survivors as compared to usual care. (Source: Value in Health)
Source: Value in Health - February 1, 2024 Category: International Medicine & Public Health Authors: Arkers Kwan Ching WONG, Shao Ling WANG, Ching SO, Jinxiao LIAN, Ying YAN, Haiyan LI, Lijie WU, Haixia PEI, Wei WANG, Frances Kam Yuet WONG Source Type: research
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation
To assess the accuracy and validity of the Determination of Diabetes Utilities, Costs, and Effects (DEDUCE) model, a Microsoft-Excel-based tool for evaluating diabetes interventions for type 1 and type 2 diabetes. (Source: Value in Health)
Source: Value in Health - January 31, 2024 Category: International Medicine & Public Health Authors: Kirk Szafranski, Gerard De Pouvourville, Dan Greenberg, Stewart Harris, Johan Jendle, Jonathan E. Shaw, JeanPierre Coaquira Castro, Yeesha Poon, Fleur Levrat-Guillen Tags: Preference-Based Assessments Source Type: research
